U

CRISPR Therapeutics

Gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.
Multinational United States
Last Update Sep 16, 2024

CRISPR Therapeutics Financials

Total funding
Capital raised
Last funding
Funding stage
Total rounds
Investors